Back to Search
MICHAEL NACHTIGAL, MD
MD
Orthopaedic Surgery Physician
NPI: 1275671380Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Dietary supplements and weight control in a middle-age population.
PMID 16296926·J Altern Complement Med·2005
8-other
Autocrine BMP4 signalling regulates ID3 proto-oncogene expression in human ovarian cancer cells.
PMID 18372118·Gene·2008
7-preclinical
Galectin-3 gene inactivation reduces atherosclerotic lesions and adventitial inflammation in ApoE-deficient mice.
PMID 18156214·Am J Pathol·2008
7-preclinical
BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells.
PMID 17272306·Carcinogenesis·2007
8-other
Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients.
PMID 17406520·Nat Protoc·2006
8-other
Valproic acid inhibits leptin secretion and reduces leptin messenger ribonucleic acid levels in adipocytes.
PMID 15331576·Endocrinology·2004
7-preclinical
Inhibition of histone deacetylase activity by valproic acid blocks adipogenesis.
PMID 14985358·J Biol Chem·2004
7-preclinical
Identification of a putative autocrine bone morphogenetic protein-signaling pathway in human ovarian surface epithelium and ovarian cancer cells.
PMID 12865307·Endocrinology·2003
8-other
The p38 MAPK inhibitor, PD169316, inhibits transforming growth factor beta-induced Smad signaling in human ovarian cancer cells.
PMID 14521923·Biochem Biophys Res Commun·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1229 E SEMINOLE ST
SPRINGFIELD, MO 65804 - Phone
- (417) 820-5610
Quick Facts
- NPI
- 1275671380
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile